on Cantourage Group SE (isin : DE000A3DSV01)
Record Revenue for Cantourage in Q1 2025
In a landmark achievement, Cantourage Group SE has reported EUR 25.6 million in revenue for the first quarter of 2025. This marks the best quarterly performance in the company's history. Remarkably, for the first time, monthly revenue exceeded EUR 10.7 million in March, surpassing the prior high of EUR 8.5 million in December 2024.
Notably, the demand for Cantourage's cannabis products continues to surge. In 2024, the company achieved EUR 51.4 million in sales, reflecting a 118% increase from 2023's EUR 23.6 million. This growth underscores Cantourage's expanding footprint in the medical cannabis sector across Europe.
Founded in 2019, Cantourage partners with over 60 cannabis growers from 18 countries, ensuring high pharmaceutical standards in production and distribution across all market segments.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news